Pan-cancer analysis reveals PRRT4 is a potential prognostic factor of AML
Background: Proline-rich transmembrane protein 4 (PRRT4) has been infrequently studied, with limited literature suggesting its potential as a prognostic marker for gastric cancer. This study aims to investigate the prognostic value of the PRRT4 gene in pan-cancer.Methods: We acquired and analyzed da...
Saved in:
| Main Authors: | Wenqiong Xiang, Fangjun Chen, Hao Zhou, Guilin Ren, Guangliang Qiang, Li Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2496544 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First results and experience with PRRT in South Africa
by: Mariza Vorster, et al.
Published: (2018-04-01) -
Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy
by: Annie Mathew, et al.
Published: (2025-04-01) -
Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
by: Chun-Wei He, et al.
Published: (2025-05-01) -
NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
by: Yusheng Liu, et al.
Published: (2025-05-01) -
Case Report: PRRT in a patient with Zollinger-Ellison syndrome. The management of gastrointestinal complications
by: Martina Di Franco, et al.
Published: (2025-05-01)